Skip to main content

Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors

  • Chapter
Progress in Basic and Clinical Immunology

Abstract

Major progresses have recently been made toward a better understanding of the molecular mechanisms regulating the NK cell function. This is primarily the result of the discovery of a number of receptors which regulate the NK cell function. Thus, the identification of various MHC-class I-specific inhibitory NK receptors (iNKR) revealed a sophisticated capability of discriminating between normal and tumor (or virally-infected) cells (1-4). All iNKR are characterized by the presence of an immunoreceptor tyrosine-based inhibition motif (ITIM) in their cytoplasmic tail (3-6). The surface expression of iNKR that inhibit the NK-cell function, explains why NK cells lyse only those target cells that have lost or express insufficient amounts of MHC class I molecules, a phenomenon that frequently occurs in tumors and virus-infected cells. Each inhibitory receptor is expressed only by a fraction of NK cells. In addition, each NK cell expresses at least one receptor specific for self-MHC alleles. As a consequence, the whole NK cell pool can sense the loss of even single MHC-class I alleles on self cells. NK cells also express surface receptors responsible for the activation during the process of natural cytotoxicity. These recently identified receptors include NKp46 (7 8), NKp30 (9) and NKp44 (10 11), collectively referred to as natural cytotoxicity receptors (NCR) (12). Another receptor which plays a complementary role with NCR in the processo of NK cell activation is NKG2D (13 14), while additional triggering surface molecules expressed by human NK cells, including 2B4 and NKp80, appear to play a role as coreceptors rather than as true receptors (15 16).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 1989; 47: 176–187

    Google Scholar 

  2. Ljunggren HG and Karre K. In search of the “missing self”. MHC molecules and NK cell recognition. Immunol. Today 1990; 11:237–244

    CAS  Google Scholar 

  3. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC and Moretta L.. Receptors for HLA-class I molecules in human Natural Killer cells. Annu. Rev. Immunol. 1996; 14: 619–648

    Article  PubMed  CAS  Google Scholar 

  4. Lanier LL. NK cell receptors. Annu. Rev. Immunol. 1998; 16:359–393

    Article  PubMed  CAS  Google Scholar 

  5. Long EO. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999; 17: 875–804

    Article  PubMed  CAS  Google Scholar 

  6. Bolland S, Ravetch JV. Inhibitory pathways triggered by ITIM containing receptors. Adv Immunol. 1999; 72: 149–177

    Article  PubMed  CAS  Google Scholar 

  7. Sivori S et al. NKp46, a novel Natural Killer cell-specific surface molecule which mediates cell activation. J.Exp. Med. 1997; 186: 1129–1136

    Article  PubMed  CAS  Google Scholar 

  8. Pessino A et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 1998. 188: 953–960

    Article  PubMed  CAS  Google Scholar 

  9. Pende D et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 1999; 190: 1505–1516

    Article  PubMed  CAS  Google Scholar 

  10. Vitale M et al. NKp44, a novel triggering surface molecule specifically expressed by activated Natural Killer cells is involved in non-MHC restricted tumor cell lysis. J. Exp. Med. 1998; 187: 2065–2072.

    Article  PubMed  CAS  Google Scholar 

  11. Cantoni C et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human Natural Killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 1999; 189:787–796

    Article  PubMed  CAS  Google Scholar 

  12. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727–729.

    Article  PubMed  CAS  Google Scholar 

  13. Pende D et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 2001; 31 (in press)

    Google Scholar 

  14. Sivori S et al. 2B4 functions as a co-receptor in human natural killer cell activation. Eur. J. Immunol. 2000; 30: 787–793

    Article  PubMed  CAS  Google Scholar 

  15. Moretta A, Biassoni R, Bottino C, Mingari MC, and Moretta L.. Natural Cytotoxicity Receptors that trigger human NK-mediated cytolysis. Immunol. Today 2000; 21:228–234.

    CAS  Google Scholar 

  16. Vitale M et al. Identification of NKp80 a novel triggering molecule expressed by human Natural Killer cells. Eur. J. Immunol. 2001; 31: 233–242

    Article  PubMed  CAS  Google Scholar 

  17. Mingari, MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi, A. Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NKrelated functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol. 1995; 7:697–703

    Article  PubMed  CAS  Google Scholar 

  18. Mingari MC et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA. 1996; 93:12433–12438

    Article  PubMed  CAS  Google Scholar 

  19. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses. Immunol. Today 1998; 19:153–157

    CAS  Google Scholar 

  20. Falco M et al. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 1999; 190:793–802

    Article  PubMed  CAS  Google Scholar 

  21. Poggi A et al. p40, a novel surface molecule involved in the regulation of the non-MHC restricted cytolytic activity in humans. Eur. J. Immunol. 1995; 25:369–376

    Article  PubMed  CAS  Google Scholar 

  22. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997; 7:283–290

    Article  PubMed  CAS  Google Scholar 

  23. Cantoni C et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells. Eur. J. Immunol. 1999; 29:3148–3159

    Article  PubMed  CAS  Google Scholar 

  24. Peiper SC, Ashmun RA, Look AT. Molecular cloning, expression, and chromosomal localization of a human gene encodong the CD33 myeloid differentiation antigen. Blood 1988; 72:314–321

    PubMed  CAS  Google Scholar 

  25. Freeman SD, Kelm S, Barber KE, and Crocker PR. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 1995; 85: 2005–2012.

    PubMed  CAS  Google Scholar 

  26. Caron PC et al. Murine and humanized constructs of monoclonal antibody M195 (antiCD33) for the therapy of acute myelogenous leukemia. Cancer 1994; 73: 1049–1056

    Article  PubMed  CAS  Google Scholar 

  27. Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, and Freeman SD. The myeloid-specific sialic acid binding receptor, CD33, associates with the protein-tyrosine phosphatases,SHP-1 and SHP-2. J.Biol.Chem. 1999; 274: 11505–11512.

    Article  PubMed  CAS  Google Scholar 

  28. Ulyanova T, Blasioli J, Woodford-Thomas TA, and Thomas ML. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur. J. Immunol. 1999; 29: 3440–3449.

    Article  PubMed  CAS  Google Scholar 

  29. Sujatha PP, Taylor LS, Stransbury EK, and McVicar DV. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 2000; 96, 483–490.

    Google Scholar 

  30. Vitale C et al. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 1999; 96: 15091–15096.

    Article  PubMed  CAS  Google Scholar 

  31. Vitale C et al. Surface Expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias. Engagement of CD33 induces apoptosis of leukemic cells. Proc.Natl.Acad.Sci. USA. 2001; in press.

    Google Scholar 

  32. Ferlazzo, G, Spaggiari GM, Semino C, Melioli G, and Moretta L. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. Eur. J. Immunol. 2000; 30: 827–833.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mingari, M.C., Vitale, C., Romagnani, C., Falco, M., Moretta, L. (2001). Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. In: Mackiewicz, A., Kurpisz, M., Żeromski, J. (eds) Progress in Basic and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 495. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0685-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0685-0_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5194-8

  • Online ISBN: 978-1-4615-0685-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics